首页> 外文OA文献 >Nuclear Factor- B Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146a
【2h】

Nuclear Factor- B Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146a

机译:核因子-B通过上调miR-146a促成甲状腺未分化癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Context: Micro-RNAs (miRNAs) have been recently involved in the modulation of several biological activities including cancer. Many human tumors show deregulated expression of miRNAs targeting oncogenes and/or tumor suppressors, thus identifying miRNAs as new molecular targets for cancer therapy. Objectives: Nuclear factor (NF)-kappaB is strongly activated in human anaplastic thyroid carcinomas (ATCs). Because the regulation of miRNA expression is under control of RNA polymerase II-dependent transcription factors, we stably inactivated NF-kappaB in the ATC-derived FRO cell line and analyzed its miRNA profile in comparison with the parental counterpart by using a miRNA chip microarray. Results: The analysis revealed that a number of miRNAs were differentially expressed in the two cell lines. Among others, the miR-146a showed a strong down-regulation that was confirmed by quantitative real time RT-PCR. The expression of miR-146a was almost undetectable in mouse embryonic fibroblasts isolated from the RelA knockout mice and was restored after reexpression of RelA, thus indicating that miR-146a transcription was controlled by NF-kappaB. The inhibition of miR-146a expression in FRO cells decreased their oncogenic potential and increased the susceptibility to chemotherapeutic drug-induced apoptosis. No difference was found in the growth rate between untransfected and miR-146a-null FRO cells. Importantly, the miR-146a resulted in overexpression of human ATC specimens compared with the normal thyroid tissue. Conclusions: Our results show that NF-kappaB contributes to anaplastic thyroid cancer up-regulating the expression of miR-146a.
机译:背景:微小RNA(miRNA)最近已经参与了包括癌症在内的几种生物活性的调节。许多人类肿瘤显示靶向致癌基因和/或肿瘤抑制因子的miRNA表达失调,因此将miRNA鉴定为癌症治疗的新分子靶标。目的:核因子(NF)-κB在人间变性甲状腺癌(ATC)中被强烈激活。因为miRNA表达的调控受RNA聚合酶II依赖性转录因子的控制,所以我们稳定地灭活了ATC衍生的FRO细胞系中的NF-kappaB,并通过使用miRNA芯片微阵列分析了其miRNA谱与亲本相比。结果:分析显示,两种细胞系中许多miRNA差异表达。其中,miR-146a显示出强烈的下调,这已通过定量实时RT-PCR证实。在从RelA基因敲除的小鼠分离的小鼠胚胎成纤维细胞中,miR-146a的表达几乎无法检测到,并且在RelA的重新表达后得以恢复,因此表明miR-146a的转录受NF-kappaB的控制。对FRO细胞中miR-146a表达的抑制降低了其致癌潜力,并增加了对化疗药物诱导的细胞凋亡的敏感性。未转染的和miR-146a-null FRO细胞之间的生长速率没有差异。重要的是,与正常甲状腺组织相比,miR-146a导致人ATC标本的过表达。结论:我们的结果表明,NF-κB有助于变性甲状腺癌上调miR-146a的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号